Your browser doesn't support javascript.
loading
Extranodal localization of non-Hodgkin's lymphoma in systemic sclerosis: A diagnostic challenge and review of the literature.
Galoppini, Giorgio; Maranini, Beatrice; Ciancio, Giovanni; Padovan, Melissa; Casoni, Gian Luca; Cavazzini, Francesco; Gafà, Roberta; Lanza, Giovanni; Govoni, Marcello.
Afiliação
  • Galoppini G; Rheumatology Unit, Department of Medical Sciences, University of Ferrara, Ferrara, Italy.
  • Maranini B; Rheumatology Unit, Department of Medical Sciences, University of Ferrara, Ferrara, Italy.
  • Ciancio G; Rheumatology Unit, Department of Medical Sciences, University of Ferrara, Ferrara, Italy.
  • Padovan M; Rheumatology Unit, Department of Medical Sciences, University of Ferrara, Ferrara, Italy.
  • Casoni GL; Pneumology Unit, Hospital of Rovigo, Rovigo, Italy.
  • Cavazzini F; Hematology Unit, Department of Medical Sciences, University of Ferrara, Ferrara, Italy.
  • Gafà R; Pathology Unit, Department of Medical Sciences, University of Ferrara, Ferrara, Italy.
  • Lanza G; Pathology Unit, Department of Medical Sciences, University of Ferrara, Ferrara, Italy.
  • Govoni M; Rheumatology Unit, Department of Medical Sciences, University of Ferrara, Ferrara, Italy.
J Scleroderma Relat Disord ; 7(3): NP1-NP6, 2022 Oct.
Article em En | MEDLINE | ID: mdl-36211199
ABSTRACT

Background:

Systemic sclerosis is associated with an increased incidence of malignancies, in particular solid neoplasms. Hematological cancers have been also observed in autoimmune diseases, though rarely present with lung involvement. The latter may be misdiagnosed in systemic sclerosis patients, due to the frequent concomitant interstitial lung disease. Case description Here, we present the case of a 63-year-old man affected by systemic sclerosis presenting with an atypical lung imaging and splenomegaly, who was diagnosed with splenic marginal zone lymphoma, thus raising the suspicion of lung secondarism. We discuss the diagnostic challenge of differential diagnosis in interstitial lung presentation and briefly review the available literature on this topic.

Conclusion:

Several reports have demonstrated an increased risk of malignancy in patients with systemic sclerosis. Still, the lack of concretely defined guidelines for systemic sclerosis, along with systemic sclerosis multifaceted organ involvement at presentation, may challenge diagnosis and management. Here, we remark the importance of clinical work-up and a multidisciplinary approach in systemic sclerosis, to early detect and treat concomitant hematological malignancies, especially during the first years of the disease.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Guideline Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Guideline Idioma: En Ano de publicação: 2022 Tipo de documento: Article